1. Background {#sec0005}
=============

In the majority of patients with a poor outcome, who are admitted to intensive care units (ICUs), there is an association with severe respiratory distress syndromes [@bib0005]. Severe community-acquired pneumonia (CAP) is usually attributed to bacterial agents, but the introduction of broader diagnostic panels with increased sensitivity have improved the diagnosis of respiratory viruses with a relevant impact on outcomes for ICU-patients [@bib0010]. Indeed, based on recent reports, viruses account for 11--55% of the total infections in patients admitted to the ICU with severe respiratory distress [@bib0005], [@bib0015], [@bib0020], [@bib0025]. However, many studies have only focused on the role of influenza A virus (e.g. H1N1pdm09) as an etiologic agent of acute respiratory failure [@bib0030], [@bib0035]. Respiratory viruses other than influenza such as human rhinovirus (HRV), human parainfluenza viruses 1-4 (hPIV1-4), human respiratory syncytial virus (hRSV) and human coronaviruses (hCoVs) are not routinely investigated in respiratory samples of ICU patients, and their role as the cause of ICU admission might be under estimated. Understanding the etiologic agents of CAP may improve treatment decisions and patient outcome. However, despite technological advances, establishing the etiologic causes of pneumonia remains a challenge.

2. Objectives {#sec0010}
=============

The aim of this study was to investigate the prevalence of respiratory viruses in patients admitted to 26 ICUs in the Lombardy Region (nearly 10 million inhabitants) during seven consecutive winter seasons (2009--2016).

3. Study design {#sec0015}
===============

3.1. Study design and patients {#sec0020}
------------------------------

Respiratory samples collected from patients admitted to 26 ICUs in the Lombardy Region with acute respiratory failure, severe pneumonia or acute respiratory distress syndrome assisted by non-invasive or mechanical ventilation or by extra-corporeal membrane oxygenation were analyzed during seven consecutive winter seasons, between November 1st and April 31st (2009--2016). Respiratory samples were collected at admission to the ICU following standard protocols and according to the physician's orders. Severe respiratory syndrome was defined as acute onset (≤1 week) respiratory failure, with hypoxemia (pO~2~/FiO~2~ ratio \<300 mmHg while on positive end-expiratory pressure or noninvasive CPAP ≥5 cmH~2~O) and bilateral opacities at chest imaging [@bib0040]. Respiratory samples were sent to the Molecular Virology Unit at the Fondazione IRCCS Policlinico San Matteo, Pavia according to the Influenza Regional Surveillance and Preparedness Plan (DGR IX/1046, 22 Dec. 2010 and DGR 5988, 30 Jun 2011). Local Ethics Committee approval was not required as the study was conducted under the auspices of the Influenza Regional Surveillance and Preparedness Plan (DGR IX/1046, 22 Dec. 2010 and DGR 5988, 30 Jun 2011).

3.2. Identification of respiratory viruses {#sec0025}
------------------------------------------

Respiratory samples were tested with a panel of laboratory-developed real-time RT-PCR or real-time PCR able to detect and quantify the following viruses [@bib0045], [@bib0050]: influenza virus A and B, including subtype determination, hPIV-3, hRSV types A and B, hCoV types −OC43, −229E, −NL63, and −HKU1, hMPV, HRV and CMV (in a subset of samples).

4. Results {#sec0030}
==========

During the study period, a total of 414 (266 male and 148 female) patients were hospitalized in 26 ICUs with severe respiratory distress. Of these, 242/414 (58.2%) patients were adults (18--65 years), 134/414 (32.4%) patients aged \>65 years, while 39/414 (9.4%) were children ([Table 1](#tbl0005){ref-type="table"} ). Overall, the median age was 56 years (range: 1 mos--86 yrs). In two seasons (2011--2012 and 2014--2015) the overall median age was higher than 60 years, while in one season (2013--2014) it was lower than 50 years. The majority of ICU patients for each year were adults (18--65 yrs), ranging from 45.5% to 66.7% of total patients, over the seven seasons. Of note, in one season (2011--12), patients aged \>65 years were the most frequently observed reaching 47.7% of the total patients analyzed ([Table 1](#tbl0005){ref-type="table"}).Table 1Age distribution of ICU-patients included in the study according to season.Table 1All seasons\
(n = 414)2009--10 (n = 56)2010--11 (n = 84)2011--12 (n = 44)2012--13 (n = 55)2013--14 (n = 36)2014--15 (n = 88)2015--16 (n = 51)Median age (range)56\
(1 mos-86)52\
(3--86)52\
(1 mo-84)63\
(1--83)57\
(9 mos-84)47\
(1--84)62\
(3 mos-84)59\
(1 mos-86)Age group (%)  \<1 year8 (1.9)0 (0.0)3 (3.6)0 (0.0)1 (1.8)0 (0.0)2 (2.3)2 (3.9) 1--5 years14 (3.4)1 (1.8)3 (3.6)1 (2.3)5 (9.1)3 (8.3)1 (1.1)0 (0.0) 6--18 years17 (4.1)4 (7.1)2 (2.4)2 (4.5)4 (7.3)2 (5.6)1 (1.1)2 (3.9) 19--65 years242 (58.2)37 (66.1)56 (66.7)20 (45.5)29 (52.7)23 (63.9)46 (52.3)30 (58.8)  \>65 years134 (32.4)14 (25.0)20 (23.8)21 (47.7)16 (29.1)8 (22.2)38 (43.2)17 (33.3)[^2]

Respiratory viruses were detected in clinical samples from the lower respiratory tract (LRT) (Broncho alveolar lavage or Broncho aspirate) during 179/414 (43.2%) CAP episodes; while respiratory viruses were detected in samples from the upper respiratory tract (URT) (nasal swab or nasopharyngeal aspirate) during 225/414 (56.8%) episodes.

A mean of 59 CAP episodes were analyzed yearly with a minimum of 36 episodes in the 2013--14 season and a maximum of 88 episodes in the 2014--2015 season. In 226/414 (54.6%) patients one or more respiratory viruses were detected, while 188/414 (45.4%) patients resulted negative. The mean positive frequency was 52.4% with a broad difference between seasons ([Fig. 1](#fig0005){ref-type="fig"} a). Indeed, the highest positive frequency (78.4%) was observed in the 2014-15 season, while the lowest (40.9%) was observed in the 2011--12 season ([Fig. 1](#fig0005){ref-type="fig"}a).Fig. 1(a) Seasonal distribution of virus-positive and virus-negative episodes of CAP in ICU-admitted patients. The total number of CAP episodes analyzed yearly are reported above each column. (b) Seasonal distribution of respiratory virus detection.Fig. 1

A single virus infection was observed in 214/226 (94.7%) patients, while in 12/226 (5.3%) at least two respiratory viruses were identified. Overall, influenza A was the most common virus identified (140/226 patients, 61.9%) followed by HRV (33/226, 14.6%), hRSV (13/226, 5.8%), influenza B virus (9/226, 4.0%), hCoVs (9/226, 4.0%), CMV (9/226, 4.0%) and human metapneumovirus (hMPV) (1/226, 0.4%). No hPIVs were detected during the study period. In mixed infections (n = 12), HRV was the most frequently detected virus (7/12, 58.3%) followed by hCoV (6/12, 50.0%), influenza A virus (5/12, 41.7%), hRSV (3/12, 25.0%), CMV (3/12, 25.0%) and influenza B virus (2/12, 16.7%) (data not shown). Influenza A virus accounted for at least 70.0% of virus-positive infections in three seasons (2009--10, 2010--11 and 2014--15) and in another three (2011--12, 2012--13 and 2015--16) seasons it was the most frequently detected virus (33.3--34.8%) ([Fig. 1](#fig0005){ref-type="fig"}b). In one season (2013--14), HRV was the most frequently detected virus (57.1% [Fig. 1](#fig0005){ref-type="fig"}b).

In pediatric patients (n = 39; 9.4% of total), 19/39 (48.7) had a viral infection, while 20/39 (51.3%) were virus-negative. In detail, in 11/19 (57.9%) positive patients HRV was detected, in 5/19 (26.3) influenza A was detected, in 2/19 (10.5%) hRSV and in 1/19 (5.3%) influenza B. Among virus-positive CAP episodes (n = 19), 14/19 (73.7%) positive samples were detected in URT samples, while 5/19 (26.3%) were detected in LRT samples. A similar distribution of samples was observed in the virus-negative pediatric group, where 14/20 (70.0%) were URT samples, and 6/20 (30.0) were LRT samples.

The proportion of infections detected in the URT as compared with the LRT samples, for respiratory viruses with at least 10 CAP episodes (influenza A, HRV and hRSV) is reported in [Table 2](#tbl0010){ref-type="table"} . hRSV was detected in LRT samples from 8/13 (61.5%) patients compared with 62/140 (44.3%) positive for influenza A and 14/33 (42.4%) positive for HRV. However, due to the low number of hRSV episodes no significant differences were observed between the observed frequencies (p \> 0.05).Table 2Distribution of influenza A, HRV and hRSV infections according to sample positivity (URT *vs* LRT).Table 2VirusAll seasons2009--102010--112011--122012--132013--142014--152015--16Influenza A\
(n = 140)URT78 (55.7)12 (63.2)18 (47.4)3 (50.0)2 (25.0)2 (50.0)37 (67.3)4 (40.0)LRT62 (44.3)7 (36.8)20 (52.6)3 (50.0)6 (75.0)2 (50.0)18 (32.7)6 (60.0)  HRV\
(n = 33)URT19 (57.6)11(50.0)2 (100.0)2 (50.0)10 (83.3)2 (25.0)1 (25.0)LRT14 (42.4)0 (0.0)1(50.0)0 (0.0)2 (50.0)2 (16.7)6 (75.0)3 (75.0)  hRSV\
(n = 13)URT5 (38.5)0 (0.0)0 (0.0)0 (0.0)2 (66.7)2 (100.0)1 (50.0)0 (0.0)LRT8 (61.5)0 (0.0)0(0.0)4(100.0)1 (33.3)0 (0.0)1 (50.0)2 (100.0)[^3]

A total of 37/414 (8.9%) patients were treated with extracorporeal membrane oxygenation (ECMO). Of these, 22/37 (64.7%) were positive for influenza A, 1/37 (2.7%) for hCoV, 1/37 (2.7%) for HRV, 1/37 (2.7%) for CMV, while 12/37 (32.4%) were virus-negative.

Regarding the nine reported CMV infection episodes, all except one patient had pre-existing co-morbidities or risk factors. In three cases, CMV was detected with at least one respiratory virus (1 hRSV, 1 HRV, and 1hCoV), while in another six cases CMV was observed as a single infection.

5. Discussion {#sec0035}
=============

The results of this study suggest that nearly half of patients admitted to the ICU (54.3%) with a severe respiratory syndrome are positive for at least one respiratory virus. Our data are in agreement with other reports focusing on viral etiologies of pneumonia in ICU patients [@bib0005], [@bib0015], [@bib0055], [@bib0060]. In these studies, the proportion of viral infections ranged from 23.0 to 49.0%. As recently summarized by Burk and colleagues, a high proportion of viral infections are observed in patients with CAP [@bib0065]. In our series, the frequency of different respiratory viruses was assessed in patients hospitalized in 26 ICUs distributed in the Lombardy Region (10 million inhabitants). These results underline the role of viruses in severe respiratory distress for all age groups. In fact, since adequate therapy for influenza is available, early diagnosis and early initiation of anti-viral therapy may improve outcomes in adult and pediatric patients [@bib0070], [@bib0075].

The use of multiplex molecular assays for the diagnosis of respiratory viruses in ICU patients has increased the proportion of viral infections detected [@bib0010], [@bib0080]. However, a major weakness of recent studies concerning CAP is that assessments are often performed using only URT samples. [@bib0065]. In fact, the use of URT samples for the diagnosis of CAP is controversial [@bib0015], [@bib0085]. Indeed, in studies that have analyzed paired URT and LRT samples, URT samples often resulted negative while positive results were observed in LRT samples [@bib0015], [@bib0045], [@bib0090], [@bib0095]. In addition, studies with \>50% LRT samples, showed a higher (44.2%) proportion of viral infections as compared with studies analyzing the etiology of CAP using URT samples only (23.5%) [@bib0065]. The high proportion of viral infections described here could indeed be related to the greater frequency (45%) of LRT samples available for the diagnosis as compared to other studies (10--20%) [@bib0065]. The importance of LRT testing is also highlighted by a recent study involving ICU patients in whom URT testing failed to detect over 40% of cases of LRT-confirmed influenza [@bib0100].

As expected, influenza A was the most common virus detected in ICU-patients [@bib0055], [@bib0085]. On the other hand, it was somewhat surprising that the second most frequently detected virus was rhinovirus (14.6%). A growing body of evidence has associated rhinovirus with lower respiratory tract disease both in adults [@bib0005], [@bib0015], [@bib0025], [@bib0060], [@bib0080] and children [@bib0105]. Indeed, in the present study, HRV was detected in LRT samples with a frequency (57.6%) similar to that observed for influenza (55.7%) and hRSV (61.5%). This finding provides new insights into the burden and severity of HRV infections. In addition, our data highlight the need for improved assays to identify respiratory viruses other than influenza especially in high-risk patients. More in general, this study underlines the importance of using molecular assays that cover a wide range of viruses for the diagnosis of respiratory infections.

In a few patients, CMV was the only virus detected, however, the importance of CMV detection in ICU-admitted patients remains questionable, especially in the absence of histologic evidence of infection [@bib0110].

The results of this study should be interpreted within the context of its limitations. The frequency of different respiratory viruses could be biased by the role of our center as a reference laboratory for the diagnosis and confirmation of severe influenza-like illness and the retrospective nature of this study limited our ability to fully collect clinical information.

In conclusion, viral infections were present in a large proportion of ICU-admitted patients with CAP. In addition to influenza A, rhinovirus was shown to account for a significant number of viral CAP episodes. Finally, the use of LRT samples appears more informative than URT samples to correctly estimate the burden of viral infections in patients with CAP.
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